Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4GT5

Crystal structure of the inactive TrkA kinase domain

Summary for 4GT5
Entry DOI10.2210/pdb4gt5/pdb
Related4GT4
DescriptorHigh affinity nerve growth factor receptor (2 entities in total)
Functional Keywordstyrosine kinase domain, transferase
Biological sourceHomo sapiens (human)
Cellular locationCell membrane; Single-pass type I membrane protein: P04629
Total number of polymer chains1
Total formula weight34867.21
Authors
Artim, S.C.,Lemmon, M.A. (deposition date: 2012-08-28, release date: 2012-09-26, Last modification date: 2023-09-13)
Primary citationArtim, S.C.,Mendrola, J.M.,Lemmon, M.A.
Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family.
Biochem.J., 448:213-220, 2012
Cited by
PubMed Abstract: To investigate the range of autoinhibitory mechanisms used by TKDs (tyrosine kinase domains) from the insulin receptor family of RTKs (receptor tyrosine kinases), we determined crystal structures of TKDs from TrkA (tropomyosin receptor kinase A, a nerve growth factor receptor) and Ror2 (receptor tyrosine kinase-like orphan receptor 2, an unconventional Wnt receptor). TrkA autoinhibition closely resembles that seen for the insulin receptor, relying on projection of an activation loop tyrosine residue into the substrate-binding site and occlusion of the ATP-binding site by the activation loop. Ror2 employs similar mechanisms, but the unusual replacement of the phenylalanine residue in its Asp-Phe-Gly motif with leucine necessitates occlusion of the ATP-binding site by other means. The unusual Asp-Leu-Gly motif in Ror2 is displaced compared with other inactive kinases, allowing the activation loop to interact directly with the TKD's αC helix, in another mode of autoinhibition that is characteristic of the other extreme of this receptor family: ALK (anaplastic lymphoma kinase) and Met. These findings provide insight into the expected range of activating mutations in these TKDs in cancer. We also describe symmetrical dimers of the inactive TrkA TKD resembling those found in other RTKs, possibly reflecting an arrangement of kinase domains in a pre-formed TrkA dimer.
PubMed: 22992069
DOI: 10.1042/BJ20121365
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.398 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon